Showing results (421-430 of 468) with videos related to
Sort By:
Pageof 47
European Journal of Preventive Cardiology|March 23, 2021
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trialRafael Diaz, Qian H Li, Deepak L Bhatt, et al.Circulation|November 12, 2019
Effect of Alirocumab on Stroke in ODYSSEY OUTCOMESJ Wouter Jukema, Laurien E Zijlstra, Deepak L Bhatt, et al.Journal of the American College of Cardiology|July 11, 2020
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCIGuillaume Marquis-Gravel, Frederik Dalgaard, Aaron D Jones, et al.Circulation|August 30, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized TrialRenato D Lopes, Celestia S Higano, Susan F Slovin, et al.American Heart Journal|March 1, 2014
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registryEmily C O'Brien, Matthew T Roe, Elizabeth S Fraulo, et al.Circulation|July 16, 2013
Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrelMatthew T Roe, Shaun G Goodman, E Magnus Ohman, et al.Journal of the American Heart Association|October 13, 2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 InhibitorsSaket Girotra, Amanda Stebbins, Lisa Wruck, et al.JAMA Cardiology|July 24, 2024
Contribution of Clinical Trial Event Data by Data Source: A Prespecified Analysis of the ADAPTABLE Randomized Clinical TrialJennifer A Rymer, Hillary Mulder, Lisa M Wruck, et al.JAMA Cardiology|July 21, 2016
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary SyndromePaul L Hess, Daniel M Wojdyla, Sana M Al-Khatib, et al.Clinical Trials (London, England)|April 1, 2017
Data monitoring committees: Promoting best practices to address emerging challengesThomas R Fleming, David L DeMets, Matthew T Roe, et al.Pageof 47